Cibc World Markets Corp Grows Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Cibc World Markets Corp increased its position in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 15.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,109 shares of the company's stock after purchasing an additional 12,728 shares during the period. Cibc World Markets Corp's holdings in Church & Dwight were worth $10,064,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Holocene Advisors LP acquired a new position in shares of Church & Dwight during the third quarter valued at about $104,795,000. State Street Corp lifted its position in Church & Dwight by 8.0% in the 3rd quarter. State Street Corp now owns 13,116,334 shares of the company's stock valued at $1,373,542,000 after acquiring an additional 969,006 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Church & Dwight during the 4th quarter valued at about $76,565,000. World Investment Advisors LLC bought a new stake in Church & Dwight during the 3rd quarter worth approximately $58,338,000. Finally, Barclays PLC raised its stake in shares of Church & Dwight by 63.9% in the third quarter. Barclays PLC now owns 1,106,131 shares of the company's stock worth $115,832,000 after purchasing an additional 431,257 shares during the last quarter. Institutional investors and hedge funds own 86.60% of the company's stock.

Insider Activity

In other Church & Dwight news, EVP Rene Hemsey sold 11,060 shares of the stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the sale, the executive vice president now directly owns 6,437 shares in the company, valued at $707,941.26. This represents a 63.21 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the transaction, the executive vice president now owns 10,497 shares of the company's stock, valued at $1,217,442.06. This trade represents a 83.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 65,570 shares of company stock worth $7,538,449. 2.00% of the stock is owned by corporate insiders.

Remove Ads

Church & Dwight Stock Performance

CHD traded down $1.03 during trading hours on Friday, hitting $107.04. The stock had a trading volume of 2,520,943 shares, compared to its average volume of 1,389,745. Church & Dwight Co., Inc. has a 1 year low of $96.35 and a 1 year high of $116.46. The company's fifty day simple moving average is $107.42 and its 200 day simple moving average is $105.88. The stock has a market cap of $26.33 billion, a PE ratio of 45.16, a price-to-earnings-growth ratio of 3.32 and a beta of 0.57. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51.

Church & Dwight (NYSE:CHD - Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter last year, the firm earned $0.65 earnings per share. Equities analysts anticipate that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were issued a $0.295 dividend. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date was Friday, February 14th. Church & Dwight's dividend payout ratio (DPR) is presently 49.79%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CHD shares. Truist Financial upped their price target on Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Monday, February 3rd. Royal Bank of Canada reiterated a "sector perform" rating and issued a $105.00 target price on shares of Church & Dwight in a research note on Monday, February 3rd. JPMorgan Chase & Co. dropped their price target on shares of Church & Dwight from $107.00 to $106.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. Barclays upped their price objective on shares of Church & Dwight from $90.00 to $93.00 and gave the stock an "underweight" rating in a research report on Tuesday, February 4th. Finally, Piper Sandler dropped their target price on shares of Church & Dwight from $128.00 to $126.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $111.56.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.